Vimarsana
Biggest News Aggregation in the World

Program In Solid Tumors News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Program In Solid Tumors. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Program In Solid Tumors Today - Breaking & Trending Today

IDEAYA Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update - Vimarsana News

IDEAYA Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update

Published: May 7, 2024

ASCO 2024 oral presentation of darovasertib neoadjuvant UM Phase 2 investigator-sponsored trial on June 3rd, and targeting neoadjuvant UM update in over 30...

Source: prnewswire.com
Related Topics:
United StatesNew South WalesAnthony JoshuaDarrin BeaupreWerner HelicaseYujiros HataAndres Ruiz BrisenoProgram In Solid TumorsMerck Sharp DohmeExchange CommissionInternational Business GmbUs Food Drug AdministrationBiosciences IncMerck Co IncProgram In TumorsKinghorn Cancer CentreAmerican Society Of Clinical OncologyHead Department Of Medical OncologyChief Executive OfficerChief Medical OfficerRecent KeyClinical OncologyBusiness GmbhPrograms UpdateDrug Administration
IDEAYA Biosciences, Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update - Vimarsana News

IDEAYA Biosciences, Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update

Published: February 20, 2024

Targeting two independent Phase 2 clinical efficacy updates for darovasertib in neoadjuvant uveal melanoma in mid-2024, including from the Phase 2 IST and Phase 2 company-sponsored studyTargeting...

Source: marketscreener.com
Related Topics:
New South WalesUnited KingdomWerner HelicaseTrodelvy Sacituzumab Govitecan HziyAnthony JoshuaAndres Ruiz BrisenoYujiros HataDarrin BeaupreExchange CommissionDarovasertib Program In TumorsProgram In Solid TumorsEuropean Society For Medical Oncology CongressCancer Research United KingdomGilead SciencesHead Department Of Medical OncologyKinghorn Cancer CentreUniversity Of ManchesterUs Food Drug AdministrationProgram In TumorsBiosciences IncUveal MelanomaChief Executive OfficerChief Medical OfficerProffered PaperMedical Oncology